急性非淋巴细胞白血病

目的观察沙利度胺和三氧化二砷（As2O3）对急性非淋巴细胞白血病（ANLL）细胞分泌血管内皮生长因子（VEGF）的影响，并观察二者是否有协同性。

Objective To investigate the effect of thalidomide and As_2O_3 to the secretion of VEGF of the cell of ANLL and study if there is coorperation in thalidomide and As_2O_3.Methods From October 2001 to February 2003,23 patients with ANLL were analyzed .

Daxx在急性非淋巴细胞白血病患儿骨髓细胞中的阳性表达率为62.5%，显著高于正常骨髓组织（P0.05）和急性淋巴细胞白血病患儿（P0.05）；

The children with acute non-lymphocytic leukemia had significantly higher Daxx expression levels ( 62.5 % ) than those with acute lymphocytic leukemia ( 26.5 % ; P0.05 ) as well as the control group ( P0.05 ) .

应用R带显带技术对151例急性非淋巴细胞白血病行细胞遗传学分析

Cytogenetic analysis on 151 cases of acute nonlymphocytic leukemia by R-banding technique

定量检测T细胞受体重排删除DNA环含量评价急性非淋巴细胞白血病患者胸腺近期输出功能

Evaluation of thymic recent output function in patients with ANLL by quantitative analysis of TRECs content

急性非淋巴细胞白血病N－ras基因突变的研究

Study on mutation of N-ras oncogene in acute non - lymphoblastic leukemia

MAC联合CsA方案治疗难治性急性非淋巴细胞白血病

Treatment of refractory acute nonlymphoblastic leukemia with MAC plus CSA regimen

急性非淋巴细胞白血病MIC分型及其与预后的关系

Study on MIC classification and its relationship with prognosis of patients with acute non-lymphocytic leukemia

目的：探讨N－ras基因突变在急性非淋巴细胞白血病（ANLL）中的作用及其意义。

To inquire into the action of N-ras oncogene mutation and its significance in the acute non-lymphoblastic leukemia ( ANLL ) .

突变p53和N-ras蛋白在老年急性非淋巴细胞白血病中的表达及临床意义

Expression and clinical significance of mutation p53 and N-ras protein in senile patients with acute non-lymphocyte cell leukemia

HAG方案治疗老年人急性非淋巴细胞白血病的疗效观察

The Therapeutic Effect of HAG Regimen on Elderly Acute Non-lymphocytic Leukemia

原癌基因C-myc、C-H-ras在急性非淋巴细胞白血病中转录水平的分析

Analysis of transcription of proto-oncogene c-myc , c-h-ras in patients with acute nonlymphocytic leukemia

HDA方案治疗急性非淋巴细胞白血病临床研究

Clinical study on the treatment of acute nonlymphoblastic leukemia with HDA regimen

急性非淋巴细胞白血病中转录因子GATA-2基因插入突变

The Insertional Mutation of Transcription Factor GATA-2 Gene in Acute Non-Lymphocytic Leukemia

31例急性非淋巴细胞白血病细胞DICKE法体外培养的观察

Study on leukemic - colony forming unit in 31 patients with acute non - lymphocytic leukemia

目的：为进一步了解急性非淋巴细胞白血病（ANLL）病人基因重排情况。

Objective : In order to get more insight into the gene rearrangement in acute non lymphoblastic leukemia ( ANLL ) .

本文对29例急性非淋巴细胞白血病（ANLL）患者的血浆血栓调节蛋白（TM）水平进行检测，发现ANLL组血浆TM水平比正常组明显升高。

The plasma concentration of thrombomodulin ( TM ) were measured in29 cases of acute non-lymphocytic leukemia ( ANLL ) . Plasma TM level significantly increased in ANLL patients .

我国在70年代将其用于急性非淋巴细胞白血病（AML）和慢性粒细胞白血病（CML）的治疗取得良好疗效。

In 70s , it had been confirmed that HHT had favorably therapeutic activity in patients with acute myelogenous leukemia ( AML ) and chronic myelogenous leukemia ( CML ) .

死亡受体DR5在急性非淋巴细胞白血病细胞中的表达及其临床意义

Expression of death receptor 5 ( DR5 ) in the cells of acute non-lymphocyte leukemia ( ANLL ) and its clinical significance

方法：RT-PCR半定量检测16种急性非淋巴细胞白血病细胞株中N-CoR的基因表达及急性早幼粒细胞白血病细胞株在维A酸作用过程中的变化。

Methods The N-CoR expression in 16 kinds of leukemia cell lines and the changes of acute promyelocytic leukemia cell lines with retinoid acid were detected using RT-PCR .

结果①成人AL异倍体检出率为35.19%，其中急性非淋巴细胞白血病（ANLL）为35.55%，急性淋巴细胞白血病（ALL）为33.33%。

Results The proportion of patients with DNA aneuploid in adult AL was 35.42 % . In acute non-lymphoblastic leukemia ( ANLL ) the aneuploid rate was 35.33 % , in acute lymphoblastic leukemia ( ALL ) 33.33 % .

目的：比较柔红霉素（rubomycin）联合阿糖胞苷（cytarabine，Ara-C）（DA方案）、米托蒽醌（mitoxantrone）联合阿糖胞苷（MA方案）治疗急性非淋巴细胞白血病（急非淋）的疗效和不良反应。

Objective : To compare the efficacy and adverse effects of rubomycin plus aracytidine ( DA ) with mitoxantrone plus aracytidine ( MA ) in the treatment of acute nonlymphocytic leukemia ( ANLL ) .

目的：明确核受体辅助抑制因子（N-CoR）在急性非淋巴细胞白血病细胞株及细胞分化过程中表达的变化，探讨其在急性白血病中的意义。

Objective To explore the expression of nuclear co-repressor ( N-CoR ) in acute non-lymphocytic leukemia cell lines and the changes of its expression during the cell differentiation .

结果：本组病例MDR1阳性表达6例（24%），以急性非淋巴细胞白血病为主，占5例，这6例MDR1阳性的急性白血病患者，没有1例经1个疗程化疗即能完全缓解；

Results : 6 cases had positive expression of MDR 1 gene ( 24 % ), amount of them acute non-lymphoblastic leukemia occupied 5 cases . No any one expressing MDR + 1 got complete remission after one course of chemotherapy .

本文对急性非淋巴细胞白血病20例、糖尿病20例及对照组30例的血浆中TFPI抗原含量与活性进行了测定。

This article represents plasma tissue factor pathway inhibitor ( TFPI ) antigen levels ( Ag ) and activity ( C ) in Acute nonlymphoblastic leukemia ( ANLL ) 20 cases , Diabetes mellitus ( NIDDM ) 20 cases and control groups 30 cases .

核受体辅助抑制因子在急性非淋巴细胞白血病细胞株中的表达

Expression of nuclear co-repressor in acute non-lymphocytic leukemia cell lines

同源核糖核酸在急性非淋巴细胞白血病联合化疗中的意义

Significance of homogenous RNA in the combined chemotherapy of ANLL

急性非淋巴细胞白血病治疗相关因素分析

Analysis of correlated factors in treatment of acute non-lymphocytic leukemia

成人急性非淋巴细胞白血病83例疗效分析

Analysis of Therapeutic Effects in 83 Adult Patients with Acute Nonlymphocytic Leukemia

急性非淋巴细胞白血病过程细胞克隆的变化

Cellular Clonal Changes in the Course of Acute Non - Lymphocytic Leukemia

体外高热对急性非淋巴细胞白血病细胞的净化作用

Study on Purification of Acute Non-lymphocytic Leukemia Cells Under Hyperthermia in Vitro